Literature DB >> 6174877

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.

E K Perry, G Blessed, B E Tomlinson, R H Perry, T J Crow, A J Cross, G J Dockray, R Dimaline, A Arregui.   

Abstract

Activities relating to 3 neurotransmitter and 4 neuropeptide systems have been examined in human temporal lobe (post mortem) for their relationships with age and Alzheimer-type changes (senile plaques and cognitive function). Significant alterations with increasing age (from 61 to 92 years) in a series of non-demented cases included a reduction of the cholinergic enzyme, choline acetyltransferase, and an increase in vasoactive intestinal peptide immunoreactivity. In cases of alzheimer's disease the only neurochemical activity investigated which correlated significantly with cognitive impairment (assessed from a Mental Test Score obtained shortly before death) and with the severity of Alzheimer-type abnormalities (senile plaques density) was choline acetyltransferase. Further analyses of the data in relation to the severity of plaque formation suggest that alterations in other neurochemical activities including reductions in dopamine-beta-hydroxylase activity, cholecystokinin octapeptide (aqueous extracted) and somatostatin immunoreactivities and an increase in substance P immunoreactivity, may occur at later stages of the disease process. These comparative data suggest that biochemical changes in this brain area associated with age and earlier stages of Alzheimer's disease may be relatively selective.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174877     DOI: 10.1016/0197-4580(81)90032-4

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

1.  The Roman strains of rats as a psychogenetic tool for pharmacological investigation of working memory: example with RU 41656.

Authors:  F Willig; D Van de Velde; J Laurent; M M'Harzi; J Delacour
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.

Authors:  Thomas Freret; Véronique Lelong-Boulouard; Pierre Lecouflet; Katia Hamidouche; François Dauphin; Michel Boulouard
Journal:  Psychopharmacology (Berl)       Date:  2017-06-19       Impact factor: 4.530

4.  Cholinergic modulation of memory in rats.

Authors:  V Haroutunian; E Barnes; K L Davis
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Cholecystokinin peptides and receptor binding in Alzheimer's disease.

Authors:  C Löfberg; J Harro; C G Gottfries; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Effect of acetylcholine on tau phosphorylation in human neuroblastoma cells.

Authors:  Alicia Rubio; Jesús Avila; Mar Pérez
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

7.  Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear.

Authors:  E Acquas; C Wilson; H C Fibiger
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

Review 8.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

Review 9.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 10.  Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review.

Authors:  Nuno G Oliveira; Daniela L Ramos; Ricardo Jorge Dinis-Oliveira
Journal:  Arch Toxicol       Date:  2020-10-24       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.